Ashwin N. Ananthakrishnan
Expertise in
16
conditions

Dr. Ashwin N. Ananthakrishnan

Gastroenterology
Massachusetts General Physicians Organization Inc
55 Fruit St, 
Boston, MA 
Accepting New Patients
Offers Telehealth
Expertise in
16
conditions
Massachusetts General Physicians Organization Inc
55 Fruit St, 
Boston, MA 
OverviewInsuranceLocationsClinical Research

Overview

Ashwin Ananthakrishnan is a Gastroenterologist in Boston, Massachusetts. Dr. Ananthakrishnan is highly rated in 16 conditions, according to our data. His top areas of expertise are Ulcerative Colitis, Hemorrhagic Proctocolitis, Crohn's Disease, Colonoscopy, and Endoscopy. Dr. Ananthakrishnan is currently accepting new patients.

His clinical research consists of co-authoring 411 peer reviewed articles and participating in 9 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Gastroenterology
Licenses
Internal Medicine in WI
Hospital Affiliations
Newton-Wellesley Hospital
Massachusetts General Hospital
North Shore Medical Center -
Brigham And Women's Hospital
Wentworth-Douglass Hospital
Languages Spoken
English
Hindi
Tamil
Urdu
Gender
Male

Insurance

Please contact the provider to confirm they accept your insurance or if you don't see your insurance listed.

Accepted insurance plans

  •  Humana

Locations

MASSACHUSETTS GENERAL PHYSICIANS ORGANIZATION INC
55 Fruit St, Boston, MA 02114
Other Locations
MASSACHUSETTS GENERAL PHYSICIANS ORGANIZATION INC
102 Endicott St, Mgh North Shore Medical, Danvers, MA 01923

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

9 Clinical Trials

Multi-center Acute Severe Ulcerative Colitis Cohort Study (MASCC)
Multi-center Acute Severe Ulcerative Colitis Cohort Study (MASCC)
Enrollment Status: Completed
Publish Date: January 24, 2025
Intervention Type: Other
A Prospective, Multi-center Registry for Patients With Short Bowel Syndrome
A Prospective, Multi-center Registry for Patients With Short Bowel Syndrome
Enrollment Status: Active_not_recruiting
Publish Date: October 15, 2024
A Phase-III, Randomized, Double-blind, Parallel-group, Placebo-controlled, International, Multicentre Study to Assess Efficacy and Safety of Cx601, Adult Allogeneic Expanded Adipose-derived Stem Cells (eASC) for the Treatment of Complex Perianal Fistula(s) in Patients With Crohn's Disease Over a Period of 24 Weeks and a Follow-up Period up to 52 Weeks
A Phase-III, Randomized, Double-blind, Parallel-group, Placebo-controlled, International, Multicentre Study to Assess Efficacy and Safety of Cx601, Adult Allogeneic Expanded Adipose-derived Stem Cells (eASC) for the Treatment of Complex Perianal Fistula(s) in Patients With Crohn's Disease Over a Period of 24 Weeks and a Follow-up Period up to 52 Weeks
Enrollment Status: Completed
Publish Date: September 19, 2024
Intervention Type: Drug, Other
Study Drug: Cx601
Study Phase: Phase 3
A Phase 3 Long-term Safety Extension Study of SHP647 in Subjects With Moderate to Severe Ulcerative Colitis or Crohn's Disease (AIDA)
A Phase 3 Long-term Safety Extension Study of SHP647 in Subjects With Moderate to Severe Ulcerative Colitis or Crohn's Disease (AIDA)
Enrollment Status: Completed
Publish Date: June 21, 2024
Intervention Type: Drug
Study Drug: Ontamalimab
Study Phase: Phase 3
A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Phase 2a Study to Evaluate the Safety, Tolerability, and Early Proof of Concept of TAK-018 for the Prevention of Postoperative Crohn's Disease Recurrence
A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Phase 2a Study to Evaluate the Safety, Tolerability, and Early Proof of Concept of TAK-018 for the Prevention of Postoperative Crohn's Disease Recurrence
Enrollment Status: Terminated
Publish Date: September 07, 2023
Intervention Type: Drug
Study Drug: TAK-018
Study Phase: Phase 2
GI Complications in Cancer Immunotherapy Patients
GI Complications in Cancer Immunotherapy Patients
Enrollment Status: Unknown
Publish Date: April 05, 2022
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Maintenance Therapy in Subjects With Moderate to Severe Ulcerative Colitis (FIGARO UC 303)
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Maintenance Therapy in Subjects With Moderate to Severe Ulcerative Colitis (FIGARO UC 303)
Enrollment Status: Completed
Publish Date: January 14, 2022
Intervention Type: Other, Drug
Study Phase: Phase 3
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Induction Therapy in Subjects With Moderate to Severe Ulcerative Colitis (FIGARO UC 301)
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Induction Therapy in Subjects With Moderate to Severe Ulcerative Colitis (FIGARO UC 301)
Enrollment Status: Terminated
Publish Date: June 14, 2021
Intervention Type: Other, Drug
Study Phase: Phase 3
A Phase 2, Multicenter, Randomized, Double-Blind, Parallel, Placebo-Controlled Study of LY3074828 in Subjects With Moderate to Severe Ulcerative Colitis
A Phase 2, Multicenter, Randomized, Double-Blind, Parallel, Placebo-Controlled Study of LY3074828 in Subjects With Moderate to Severe Ulcerative Colitis
Enrollment Status: Completed
Publish Date: June 17, 2020
Intervention Type: Drug
Study Phase: Phase 2
View 8 Less Clinical Trials

409 Total Publications

Reply to Owen et al.
Reply to Owen et al.
Journal: Gastroenterology
Published: January 21, 2025
Similar Doctors
Expertise in
44
conditions
Dr. Christopher Thompson
Gastroenterology
Expertise in
44
conditions
Dr. Christopher Thompson
Gastroenterology

Brigham And Womens Physicians Organization Inc

75 Francis St, 
Boston, MA 
 (2.7 mi)
617-732-5500
Languages Spoken:
English
Offers Telehealth

Christopher Thompson is a Gastroenterologist in Boston, Massachusetts. Dr. Thompson is highly rated in 44 conditions, according to our data. His top areas of expertise are Obesity, Esophageal Varices, Gastrointestinal Fistula, Endoscopy, and Gastric Bypass.

Gilaad G. Kaplan
Expertise in
20
conditions
Dr. Gilaad G. Kaplan
Gastroenterology
Expertise in
20
conditions
Dr. Gilaad G. Kaplan
Gastroenterology
Massachusetts General Hospital, 55 Fruit Street, 
Boston, MA 
 (0.1 mi)
617-726-3673
Languages Spoken:
English

Gilaad Kaplan is a Gastroenterologist in Boston, Massachusetts. Dr. Kaplan is highly rated in 20 conditions, according to our data. His top areas of expertise are Viral Gastroenteritis, Crohn's Disease, Colitis, Endoscopy, and Colonoscopy.

Hamed S. Khalili
Expertise in
25
conditions
Dr. Hamed S. Khalili
Gastroenterology
Expertise in
25
conditions
Dr. Hamed S. Khalili
Gastroenterology

The General Hospital Corporation

55 Fruit St, 
Boston, MA 
617-726-2000
Languages Spoken:
English, Farsi
See accepted insurances
Accepting New Patients
Offers Telehealth

Hamed Khalili is a Gastroenterologist in Boston, Massachusetts. Dr. Khalili is highly rated in 25 conditions, according to our data. His top areas of expertise are Lymphocytic Colitis, Ulcerative Colitis, Crohn's Disease, Endoscopy, and Colonoscopy. Dr. Khalili is currently accepting new patients.

Areas of Expertise

When evaluating expertise, MediFind pulls from factors such as the number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

To learn more about how MediFind determines the expertise levels, check out our expert tiers page.

Search for your specific condition
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile